| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PARAMOUNT BED Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LUCID DIAGNOSTICS | 1,135 | +2,25 % | Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection | Report includes nearly 12,000 patients who underwent Lucid's EsoGuard® Esophageal DNA Test on samples collected using its EsoCheck® Esophageal Cell Collection Device
Real-world... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,640 | +2,98 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| GENEDX | 136,32 | +0,28 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| HEARTFLOW | 28,650 | +8,98 % | Why AI Stock HeartFlow Triumphed on Thursday | ||
| PROCEPT BIOROBOTICS | 32,710 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| BETA BIONICS | 29,050 | -0,48 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ADAPTHEALTH | 10,230 | -2,39 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| ALIGNMENT HEALTHCARE | 20,400 | -0,73 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 26,170 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| PACS GROUP | 35,390 | +1,92 % | PACS Group: UBS senkt Kursziel auf 42 US-Dollar, bleibt aber bei Kaufempfehlung | ||
| SIEMENS HEALTHINEERS | 44,580 | -0,31 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,940 | +0,43 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTBEAM | 2,705 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| RXSIGHT | 12,315 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,445 | 0,00 % | HeartFocus Launches First Clinical Product in the U.S. With Butterfly Network | FDA-cleared AI-guided cardiac imaging software now available for all U.S healthcare professionals HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech... ► Artikel lesen |